This resulted in the down-regulation of Msr1 (Fig. 7i) and at least a four-fold decrease in BODIPY staining on the tumor-derived DCs that were incubated with anti-Msr1 compared to those tumor-derived DCs that did not receive the Msr1 antibody (MFI 2669 and 630, respectively)(Fig. 7j). Here, MSR1 is linked to neoplasm.